cancer of the floor of the mouthsurgical treatmentsquamous cell carcinomaoncological effectivenessearly stage cancer of the floor of the mouthрак дна полости ртахирургическое лечениеплоскоклеточный раконкологическая эффективностьранние стадии рака дна полости рта1.1. Клинические рекомендации по лечению опухолей головы и шеи: Справочник специалиста по лечению опухолей головы и шеи. М.: АБВ-пресс, 2011. [Clinical guidelines for treatment of neck and head tumors: Reference book for specialists in head and neck tumors. Moscow: ABV-Press, 2001. (In Russ.)].Клинические рекомендации по лечению опухолей головы и шеи: Справочник специалиста по лечению опухолей головы и шеи. М.: АБВ-пресс, 2011. [Clinical guidelines for treatment of neck and head tumors: Reference book for specialists in head and neck tumors. Moscow: ABV-Press, 2001. (In Russ.)].2.2. Pimenta Amaral T.M., da Silva Freire A.R., Carvalho A.L. et al. Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth. Oral Oncol 2004;4(8):780–6. DOI: 10.1016/j.oraloncology. 2003.10.009. PMID: 15288831.Pimenta Amaral T.M., da Silva Freire A.R., Carvalho A.L. et al. Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth. Oral Oncol 2004;4(8):780–6. DOI: 10.1016/j.oraloncology. 2003.10.009. PMID: 15288831.3.3. Garziano-Demo P., Dell, Acqua A., Dalmasso P. et al. Clinicopathologic parameters and outcome of 245 patients operated of oral squamous cell carcinoma. J Craniomaxillofac Surg 2006;34(6):344–50. DOI: 10.1016/j.jcms.2006.04.004. PMID: 16859913.Garziano-Demo P., Dell, Acqua A., Dalmasso P. et al. Clinicopathologic parameters and outcome of 245 patients operated of oral squamous cell carcinoma. J Craniomaxillofac Surg 2006;34(6):344–50. DOI: 10.1016/j.jcms.2006.04.004. PMID: 16859913.4.4. Peng K., Chu A., Lai C. et al. Is there a role for neck dissection in T1 oral tongue squamous cell carcinoma? The UCLA experience. Am J Otolaryngol 2014;35(6):741–6. DOI: 10.1016/j.amjoto.2014.06.019. PMID: 25091179.Peng K., Chu A., Lai C. et al. Is there a role for neck dissection in T1 oral tongue squamous cell carcinoma? The UCLA experience. Am J Otolaryngol 2014;35(6):741–6. DOI: 10.1016/j.amjoto.2014.06.019. PMID: 25091179.5.5. Pezier T., Nixon I., Gurney B. et al. Sentinel lymph node biopsy for T1/T2 oral cavity squamous cell carcinoma – a prospective case series. Ann Surg Oncol 2012;19 (11):3528–33. DOI: 10.1245/s10434-011-2207-0. PMID: 22411202.Pezier T., Nixon I., Gurney B. et al. Sentinel lymph node biopsy for T1/T2 oral cavity squamous cell carcinoma – a prospective case series. Ann Surg Oncol 2012;19 (11):3528–33. DOI: 10.1245/s10434-011-2207-0. PMID: 22411202.6.6. Канаев С.В. Лучевая терапия злокачественных опухолей головы и шеи. Практическая онкология 2003;4(1):15–24. [Kanaev S.V. Beam therapy of malignant tumors of the head and neck. Prakticheskaya onkologiya = Practical oncology 2003;4(1):15–24. (In Russ.)].Канаев С.В. Лучевая терапия злокачественных опухолей головы и шеи. Практическая онкология 2003;4(1):15–24. [Kanaev S.V. Beam therapy of malignant tumors of the head and neck. Prakticheskaya onkologiya = Practical oncology 2003;4(1):15–24. (In Russ.)].7.7. Геворков. А.Р. Индивидуализация показаний к проведению лучевого, химиолучевого лечения больных плоскоклеточным раком языка. Автореф. дис. … канд. мед. наук. М., 2013. [Gevorkov A.R. Individualization of indications for beam therapy, chemoradiation treatment in patients with squamous cell carcinoma of the tongue. Ph. D. dissertation summary. Moscow, 2013. (In Russ.)].Геворков. А.Р. Индивидуализация показаний к проведению лучевого, химиолучевого лечения больных плоскоклеточным раком языка. Автореф. дис. … канд. мед. наук. М., 2013. [Gevorkov A.R. Individualization of indications for beam therapy, chemoradiation treatment in patients with squamous cell carcinoma of the tongue. Ph. D. dissertation summary. Moscow, 2013. (In Russ.)].8.8. Семин Д.Ю. Одновременная химиолучевая терапия рака слизистой оболочки полости рта и ротоглотки. Вопросы онкологии 2010;56(5):544–7. [Siomin D.Yu. Concurrent radiochemotherapy in the treatment of squamous cell oral and oropharyngeal cancer. Voprosy onkologii = Problems in Oncology 2010;56(5):544–7. (In Russ.)].Семин Д.Ю. Одновременная химиолучевая терапия рака слизистой оболочки полости рта и ротоглотки. Вопросы онкологии 2010;56(5):544–7. [Siomin D.Yu. Concurrent radiochemotherapy in the treatment of squamous cell oral and oropharyngeal cancer. Voprosy onkologii = Problems in Oncology 2010;56(5):544–7. (In Russ.)].9.9. Henk K. Treatment of oral cancer by interstitial irradiation using iridium-192. Br J Oral Maxillofac Surg 1992;30(6):355–9. DOI: 10.1016/0266–4356 (92) 90200–3. PMID: 1450156.Henk K. Treatment of oral cancer by interstitial irradiation using iridium-192. Br J Oral Maxillofac Surg 1992;30(6):355–9. DOI: 10.1016/0266–4356 (92) 90200–3. PMID: 1450156.10.10. Dik E., Willems S., Ipenburg N. et al. Resection of early oral squamous cell carcinoma with positive or close margins: relevance of adjuvant treatment in relation to local recurrence: margins of 3 mm as safe as 5 mm. Oral Oncology 2014;50(6):611–5. DOI: 10.1016/j.oraloncology. 2014.02.014 PMID: 24630900.Dik E., Willems S., Ipenburg N. et al. Resection of early oral squamous cell carcinoma with positive or close margins: relevance of adjuvant treatment in relation to local recurrence: margins of 3 mm as safe as 5 mm. Oral Oncology 2014;50(6):611–5. DOI: 10.1016/j.oraloncology. 2014.02.014 PMID: 24630900.11.11. Dwivedi R.C., St Rose S., Chisholm E.J.et al. Evaluation of factors affecting posttreatment quality of life in oral and oropharyngeal cancer patients primarily treated with curative surgery: an exploratory study. Eur Arch Otorhinolaryngol 2012;269(2):591–9. DOI: 10.1007/s00405-011-1621-z. PMID: 21553147.Dwivedi R.C., St Rose S., Chisholm E.J.et al. Evaluation of factors affecting posttreatment quality of life in oral and oropharyngeal cancer patients primarily treated with curative surgery: an exploratory study. Eur Arch Otorhinolaryngol 2012;269(2):591–9. DOI: 10.1007/s00405-011-1621-z. PMID: 21553147.12.12. Zhang T., Lubek J., Salama A. et al. Treatment of cT1N0M0 tongue cancer: outcome and prognostic parameters. J Oral Maxillofac Surg 2014;72(2):406–14. DOI: 10.1016/j.joms.2013.05.028. PMID: 24045188.Zhang T., Lubek J., Salama A. et al. Treatment of cT1N0M0 tongue cancer: outcome and prognostic parameters. J Oral Maxillofac Surg 2014;72(2):406–14. DOI: 10.1016/j.joms.2013.05.028. PMID: 24045188.13.13. Fukano H., Matsuura H., Hasegawa Y. et al. Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma. Head Neck 1997;19(3):205–10. PMID: 9142520.Fukano H., Matsuura H., Hasegawa Y. et al. Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma. Head Neck 1997;19(3):205–10. PMID: 9142520.14.14. Balasubramanian D., Ebrahimi A., Gupta R. et al. Tumour thickness as a predictor of nodal metastases in oral cancer: comparison between tongue and floor of mouth subsites. Oral Oncology 2014;50(12):1165–8. DOI: 10.1016/j.oraloncology.2014.09.012. PMID: 25307875.Balasubramanian D., Ebrahimi A., Gupta R. et al. Tumour thickness as a predictor of nodal metastases in oral cancer: comparison between tongue and floor of mouth subsites. Oral Oncology 2014;50(12):1165–8. DOI: 10.1016/j.oraloncology.2014.09.012. PMID: 25307875.15.15. Rigual N., Douglas W., Lamonica D. et al. Sentinel lymph node biopsy: a rational approach for staging T2N0 oral cancer. Laryngoscope 2006; 115(12):2217–20. DOI: 10.1097/01.mlg.0000187870.82699.ed. PMID: 16369170.Rigual N., Douglas W., Lamonica D. et al. Sentinel lymph node biopsy: a rational approach for staging T2N0 oral cancer. Laryngoscope 2006; 115(12):2217–20. DOI: 10.1097/01.mlg.0000187870.82699.ed. PMID: 16369170.16.16. Deganello A., Manciocco V., Dolivet G. et al. Infrahyoid fascio-myocutaneous flap as an alternative to free radial forearm flap in head and neck reconstruction. Head Neck 2007;29(3):285–91. DOI: 10.1002/hed.20512. PMID: 17230563.Deganello A., Manciocco V., Dolivet G. et al. Infrahyoid fascio-myocutaneous flap as an alternative to free radial forearm flap in head and neck reconstruction. Head Neck 2007;29(3):285–91. DOI: 10.1002/hed.20512. PMID: 17230563.17.17. You Y., Chen W., Wang Y. et al. The feasibility of facial-submental artery island myocutaneous flaps for reconstructing defects of the oral floor following cancer ablation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109(6):e12–e6. DOI:10.1016/j.tripleo.2010.02.004. PMID: 20451829.You Y., Chen W., Wang Y. et al. The feasibility of facial-submental artery island myocutaneous flaps for reconstructing defects of the oral floor following cancer ablation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109(6):e12–e6. DOI:10.1016/j.tripleo.2010.02.004. PMID: 20451829.18.18. Leon X., Quer M., Diez S. et al. Second neoplasm in patients with head and neck cancer. Head Neck 1999;21(3):204–10. PMID: 10208662.Leon X., Quer M., Diez S. et al. Second neoplasm in patients with head and neck cancer. Head Neck 1999;21(3):204–10. PMID: 10208662.19.19. Yamamoto E., Shibuya H., Yoshimura R. et al. Site specific dependency of second primary cancer in early stage head and neck squamous cell carcinoma. Cancer 2002;94(7):2007–14. DOI: 10.1002/cncr.10444. PMID: 11932903.Yamamoto E., Shibuya H., Yoshimura R. et al. Site specific dependency of second primary cancer in early stage head and neck squamous cell carcinoma. Cancer 2002;94(7):2007–14. DOI: 10.1002/cncr.10444. PMID: 11932903.20.20. Strojan P., Corry J., Eisbruch A. et al. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate. Head Neck 2015;37(1):134–50. DOI: 10.1002/hed.23542. PMID: 24481720.Strojan P., Corry J., Eisbruch A. et al. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate. Head Neck 2015;37(1):134–50. DOI: 10.1002/hed.23542. PMID: 24481720.